301. Perturbation of B-cell development in mice overexpressing the Bcl-2 homolog A1
- Author
-
Stephen Chen, Dennis M. Willerford, Peter I. Chuang, Chien Ying Liu, Samantha Morefield, and John M. Harlan
- Subjects
Programmed cell death ,Lymphoma ,Cell Survival ,Transgene ,T-Lymphocytes ,Immunology ,bcl-X Protein ,Mice, Transgenic ,Thymus Gland ,Biology ,Biochemistry ,Minor Histocompatibility Antigens ,Mice ,Immune system ,medicine ,Animals ,B cell ,Gene Rearrangement ,B-Lymphocytes ,Genes, Immunoglobulin ,Cell growth ,Cell Biology ,Hematology ,Acquired immune system ,Cell biology ,medicine.anatomical_structure ,Enhancer Elements, Genetic ,Proto-Oncogene Proteins c-bcl-2 ,Apoptosis ,Immune System ,biology.protein ,Antibody - Abstract
Decisions about cell survival or death are central components of adaptive immunity and occur at several levels in immune system development and function. The Bcl-2 family of homologous proteins plays an important role in these decisions in lymphoid cells. Bcl-2, Bcl-xL, and A1 are differentially expressed during B- and T-cell development, and they have shared and distinct roles in regulating cell death. We sought to gain insight into the role of A1 in immune system development and function. A murine A1-a transgene was expressed under the control of the Eμ enhancer, and mice with A1 overexpression in B- and T-cell lineages were derived. Thymocytes and early B cells in Eμ-A1 mice showed extended survival. B-lineage development was altered, with expansion of the pro–B cell subset at the expense of pre–B cells, suggesting an impairment of the pro– to pre–B-cell transition. This early B-cell phenotype resembled Eμ–Bcl-xL mice but did not preferentially rescue cells with completed V(D)J rearrangements of the immunoglobulin heavy chain. In contrast to Eμ–Bcl-2 transgenes, A1 expression in pro–B cells did not rescue pre–B-cell development in SCID mice. These studies indicate that A1 protects lymphocytes from apoptosis in vitro but that it has lineage- and stage-specific effects on lymphoid development. Comparison with the effects of Bcl-2 and Bcl-xL expressed under similar control elements supports the model that antiapoptotic Bcl-2 homologs interact differentially with intracellular pathways affecting development and apoptosis in lymphoid cells.
- Published
- 2002